IL-1β and TNF-α regulation of the adenosine receptor (A 2A) expression: Differential requirement for NF-κB binding to the proximal promoter

Journal of Immunology

Volumn 177, Issue 10, 2006, Pages 7173-7183

  Morello, Silvana ^a,b   Ito, Kazuhiro ^a   Yamamura, Satoshi ^a   Lee, Kang Yun ^a   Jazrawi, Elen ^a   DeSouza, Patricia ^a   Barnes, Peter ^a   Cicala, Carla ^b   Adcock, Ian M ^a,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR; AS 602868; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN; PROTEIN P50; PROTEIN P52; RECEPTOR SUBTYPE; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADENOSINE RECEPTOR GENE; AIRWAY CONSTRICTION; ARTICLE; BINDING SITE; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR GENE;

EID: 33750821379     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.10.7173     Document Type: Article

References (65)

1. Klinger, M., M. Freissmuth, and C. Nanoff. 2002. Adenosine receptors: G protein-mediated signaling and the role of accessory proteins. Cell Signal. 14: 99-108.
2. Welch, W. J. 2002. Adenosine type 1 receptor antagonists in fluid retaining disorders. Expert. Opin. Invest. Drugs 11: 1553-1562.
3. Cohen, M. V., C. P. Baines, and J. M. Downey. 2000. Ischemic preconditioning: from adenosine receptor to KATP channel. Annu. Rev. Physiol. 62: 79-109.
4. Marquardt, D. L. 1998. Mast cell adenosine receptor characteristics and signaling. Adv. Exp. Med. Biol. 431: 79-82.
5. Burnstock, G. 2002. Purinergic signaling and vascular cell proliferation and death. Arterioscler. Thromb. Vasc. Biol. 22: 364-373.
6. Abbracchio, M. P., S. Ceruti, R. Brambilla, C. Franceschi, W. Malorni, K. A. Jacobson, D. K. von Lubitz, and F. Cattabeni. 1997. Modulation of apoptosis by adenosine in the central nervous system: a possible role for the A3 receptor: pathophysiological significance and therapeutic implications for neurodegenerative disorders. Ann. NY Acad. Sci. 825: 11-22.
7. Ohana, G., S. Bar-Yehuda, F. Barer, and P. Fishman. 2001. Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor. J. Cell. Physiol. 186: 19-23.
8. Livingston, M., L. G. Heaney, and M. Ennis. 2004. Adenosine, inflammation and asthma - a review. Inflamm. Res. 53: 171-178.
9. Fozard, J. R., and J. P. Hannon. 1999. Adenosine receptor ligands: potential as therapeutic agents in asthma and COPD. Pulm. Pharmacol. Ther. 12: 111-114.
10. Cushley, M. J., A. E. Tattersfield, and S. T. Holgate. 1983. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br. J Clin. Pharmacol. 15: 161-165.
11. Oosterhoff, Y., J. W. de Jong, M. A. Jansen, G. H. Koeter, and D. S. Postma. 1993. Airway responsiveness to adenosine 5′-monophosphate in chronic obstructive pulmonary disease is determined by smoking. Am. Rev. Respir. Dis. 147: 553-558.
12. Eppell, B. A., A. M. Newell, and E. J. Brown. 1989. Adenosine receptors are expressed during differentiation of monocytes to macrophages in vitro. Implications for regulation of phagocytosis. J. Immunol. 143: 4141-4145.
13. Nemeth, Z. H., S. J. Leibovich, E. A. Deitch, E. S. Vizi, C. Szabo, and G. Hasko. 2003. cDNA microarray analysis reveals a nuclear factor-κB- independent regulation of macrophage function by adenosine. J. Pharmacol. Exp. Ther. 306: 1042-1049.
14. Apasov, S., M. Koshiba, F. Redegeld, and M. V. Sitkovsky. 1995. Role of extracellular ATP and P1 and P2 classes of purinergic receptors in T-cell development and cytotoxic T lymphocyte effector functions. Immunol. Rev. 146: 5-19.
15. Walker, B. A., M. A. Jacobson, D. A. Knight, C. A. Salvatore, T. Weir, D. Zhou, and T. R. Bai. 1997. Adenosine A3 receptor expression and function in eosinophils. Am. J. Respir. Cell Mol. Biol. 16: 531-537.
16. Krzanowski, J. J., A. Urdaneta-Bohorquez, J. B. Polson, Y. Sakamoto, and A. Szentivanyi. 1987. Effects of adenosine and theophylline on canine tracheal smooth muscle tone. Arch. Int. Pharmacodyn. Ther. 287: 224-236.
17. Johnson, H. G., and M. L. McNee. 1985. Adenosine-induced secretion in the canine trachea: modification by methylxanthines and adenosine derivatives. Br. J. Pharmacol. 86: 63-67.
18. Clancy, J. P., F. E. Ruiz, and E. J. Sorscher. 1999. Adenosine and its nucleotides activate wild-type and R117H CFTR through an A2B receptor-coupled pathway. Am. J. Physiol. 276: C361-C369.
19. Carre, D. A., C. H. Mitchell, K. Peterson-Yantorno, M. Coca-Prados, and M. M. Civan. 1997. Adenosine stimulates Cl- channels of nonpigmented ciliary epithelial cells. Am. J. Physiol. 273: C1354-C1361.
20. Musante, L., O. Zegarra-Moran, P. G. Montaldo, M. Ponzoni, and L. J. Galietta. 1999. Autocrine regulation of volume-sensitive anion channels in airway epithelial cells by adenosine. J. Biol. Chem. 274: 11701-11707.
21. Bouritius, H., and J. A. Groot. 1997. Apical adenosine activates an amiloride-sensitive conductance in human intestinal cell line HT29cl.19A. Am. J. Physiol. 272: C931-C936.
22. + channels in A6 distal nephron cells. Am. J. Physiol. 270: F798-F805.
23. - currents in normal and cystic fibrosis airway epithelial cells. J. Biol. Chem. 268: 24779-24784.
24. Hughes, P. J., S. T. Holgate, and M. K. Church. 1984. Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism. Biochem. Pharmacol. 33: 3847-3852.
25. Peachell, P. T., L. M. Lichtenstein, and R. P. Schleimer. 1991. Differential regulation of human basophil and lung mast cell function by adenosine. J Pharmacol. Exp. Ther. 256: 717-726.
26. Suzuki, H., M. Takei, T. Nakahata, and H. Fukamachi. 1998. Inhibitory effect of adenosine on degranulation of human cultured mast cells upon cross-linking of FcεRI. Biochem. Biophys. Res. Commun. 242: 697-702.
27. Arslan, G., E. Kontny, and B. B. Fredholm. 1997. Down-regulation of adenosine A2A receptors upon NGF-induced differentiation of PC12 cells. Neuropharmacology 36: 1319-1326.
28. Navarro, A., R. Zapata, E. I. Canela, J. Mallol, C. Lluis, and R. Franco. 1999. Epidermal growth factor (EGF)-induced up-regulation and agonist- and antagonist-induced desensitization and internalization of A1 adenosine receptors in a pituitary-derived cell line. Brain Res. 816: 47-57.
29. 2A receptors in rat brain. J. Pharmacol. Exp. Ther. 280: 1094-1101.
30. Ren, H., and G. L. Stiles. 1999. Dexamethasone stimulates human A1 adenosine receptor (A1AR) gene expression through multiple regulatory sites in promoter B. Mol. Pharmacol. 55: 309-316.
31. 2A receptors in human monocytic THP-1 cells. J. Immunol. 167: 4026-4032.
32. 2A adenosine receptors by proinflammatory cytokines in rat PC12 cells. Biochem. Pharmacol. 64: 625-631.
33. Gessi, S., K. Varani, S. Merighi, E. Cattabriga, A. Avitabile, R. Gavioli, C. Fortini, E. Leung, L. S. Mac, and P. A. Borea. 2004. Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation. Mol. Pharmacol. 65: 711-719.
34. 2-terminal kinase. J. Biol. Chem. 274: 35499-35504.
35. Xaus, J., M. Mirabel, J. Lloberas, C. Soler, C. Lluis, R. Franco, and A. Celada. 1999. IFN-γ up-regulates the A2B adenosine receptor expression in macrophages: a mechanism of macrophage deactivation. J. Immunol. 162: 3607-3614.
36. Varani, K., G. Caramori, F. Vincenzi, I. Adcock, P. Casolari, E. Leung, S. Maclennan, S. Gessi, S. Morello, P. J. Barnes, K. Ito, K. F. Chung, G. Cavallesco, G. Azzena, A. Papi, and P. A. Borea. 2006. Alteration of Adenosine receptors in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 173: 398-406.
37. Barnes, P. J., and S. Kleinert. 2004. COPD-a neglected disease. Lancet 364: 564-565.
38. Davies, D. E. 2001. The bronchial epithelium: translating gene and environment interactions in asthma. Curr. Opin. Allergy Clin. Immunol. 1: 67-71.
39. + current in human airway epithelial cells by exogenous and autocrine adenosine. Am. J. Physiol. 281: C1991-C2002.
40. Wright, L. C., J. Seybold, A. Robichaud, I. M. Adcock, and P. J. Barnes. 1998. Phosphodiesterase expression in human epithelial cells. Am. J. Physiol 275: L694-L700.
41. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
42. Ito, K., P. J. Barnes, and I. M. Adcock. 2000. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1β-induced histone H4 acetylation on lysines 8 and 12. Mol. Cell. Biol. 20: 6891-6903.
43. Quandt, K., K. Frech, H. Karas, E. Wingender, and T. Werner. 1995. Matlnd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23: 4878-4884.
44. Wingender, E., A. E. Kel, O. V. Kel, H. Karas, T. Heinemeyer, P. Dietze, R. Knuppel, A. G. Romaschenko, and N. A. Kolchanov. 1997. TRANSFAC, TRRD and COMPEL: towards a federated database system on transcriptional regulation. Nucleic Acids Res. 25: 265-268.
45. Thanos, D., and T. Maniatis. 1995. Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome. Cell 83: 1091-1100.
46. Elias, J. A., and V. Lentz. 1990. IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. J. Immunol 145: 161-166.
47. Leverkus, M., M. Yaar, M. S. Eller, E. H. Tang, and B. A. Gilchrest. 1998. Post-transcriptional regulation of UV induced TNF-α expression. J. Invest. Dermatol. 110: 353-357.
48. Levy, N. S., S. Chung, H. Furneaux, and A. P. Levy. 1998. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem. 273: 6417-6423.
49. Newton, R., I. M. Adcock, and P. J. Barnes. 1996. Superinduction of NF-κB by actinomycin D and cycloheximide in epithelial cells. Biochem. Biophys. Res. Commun. 218: 518-523.
50. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-κB puzzle. Cell 109(Suppl.): S81-S96.
51. Barnes, P. J., and M. Karin. 1997. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336: 1066-1071.
52. Baldwin, A. S., Jr. 2001. Series introduction: the transcription factor NF-κB and human disease. J. Clin. Invest. 107: 3-6.
53. Frelin, C., V. Imbert, E. Griessinger, A. Loubat, M. Dreano, and J. F. Peyron. 2003. AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-α in Jurkat leukemic cells. Oncogene 22: 8187-8194.
54. Karin, M., Z. Liu, and E. Zandi. 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9: 240-246.
55. Widmann, C., S. Gibson, M. B. Jarpe, and G. L. Johnson. 1999. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79: 143-180.
56. Lewis, T. S., P. S. Shapiro, and N. G. Ahn. 1998. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74: 49-139.
57. Whitmarsh, A. J., and R. J. Davis. 1999. Signal transduction by MAP kinases: regulation by phosphorylation-dependent switches. Sci. STKE 1999: PE1.
58. Whitmarsh, A. J., and R. J. Davis. 1996. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74: 589-607.
59. Bain, J., H. McLauchlan, M. Elliott, and P. Cohen. 2003. The specificities of protein kinase inhibitors: an update. Biochem. J. 371: 199-204.
60. Bennett, B. L., D. T. Sasaki, B. W. Murray, E. C. O'Leary, S. T. Sakata, W. Xu, J. C. Leisten, A. Motiwala, S. Pierce, Y. Satoh, S. S. Bhagwat, A. M. Manning, and D. W. Anderson. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98: 13681-13686.
61. Taylor, B. S., M. E. de Vera, R. W. Ganster, Q. Wang, R. A. Shapiro, S. M. Morris, Jr., T. R. Billiar, and D. A. Geller. 1998. Multiple NF-κB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J. Biol. Chem. 273: 15148-15156.
62. Wada, H., M. Kagoshima, K. Ito, P. J. Barnes, and I. M. Adcock. 2005. 5-Azacytidine suppresses RNA polymerase II recruitment to the SLPI gene. Biochem. Biophys. Res. Commun. 331: 93-99.
63. Nguyen, D. K., M. C. Montesinos, A. J. Williams, M. Kelly, and B. N. Cronstein. 2003. Th1 cytokines regulate adenosine receptors and their downstream signaling elements in human microvascular endothelial cells. J. Immunol. 171: 3991-3998.
64. Fortin, A., D. Harbour, M. Fernandes, P. Borgeat, and S. Bourgoin. 2006. Differential expression of adenosine receptors in human neutrophils: up-regulation by specific Th1 cytokines and lipopolysaccharide. J. Leukocyte Biol. 79: 574-585.
65. 2A adenosine receptor expression by TNF-α in PBMC of patients with CHF: a regulatory mechanism of inflammation. J. Card. Fail. 11: 67-73.